BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 24140661)

  • 1. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
    J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
    Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
    Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    Ahmed AI; Abebe AT; Han Y; Alnabelsi T; Agrawal T; Kassi M; Aljizeeri A; Taylor A; Tleyjeh IM; Al-Mallah MH
    J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of newly diagnosed sarcoidosis in patients with ventricular arrhythmias: a cardiac magnetic resonance and 18F-FDG cardiac PET study.
    Kebed KY; Carter SV; Flatley E; Ward RP; Moss JD; Appelbaum DE; Singh A; Lang RM; Tung R; Patel AR
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1361-1369. PubMed ID: 33225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of serial quantitative evaluation of
    Muser D; Santangeli P; Castro SA; Liang JJ; Enriquez A; Werner TJ; Nucifora G; Magnani S; Hayashi T; Zado ES; Garcia FC; Callans DJ; Dixit S; Desjardins B; Marchlinski FE; Alavi A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1394-1404. PubMed ID: 29610956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
    Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis.
    Bekki M; Tahara N; Tahara A; Sugiyama Y; Maeda-Ogata S; Honda A; Igata S; Enomoto M; Kakuma T; Kaida H; Abe T; Fukumoto Y
    J Nucl Cardiol; 2022 Oct; 29(5):2132-2144. PubMed ID: 34228338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in ¹⁸F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis.
    Osborne MT; Hulten EA; Singh A; Waller AH; Bittencourt MS; Stewart GC; Hainer J; Murthy VL; Skali H; Dorbala S; Di Carli MF; Blankstein R
    J Nucl Cardiol; 2014 Feb; 21(1):166-74. PubMed ID: 24307261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of serial
    Okafor J; Khattar R; Kouranos V; Ohri S; Diana D; Ebeke E; Azzu A; Ahmed R; Wells A; Baksi AJ; Sharma R; Wechalekar K
    J Nucl Cardiol; 2024 May; 35():101842. PubMed ID: 38479574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
    Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Cardiac Magnetic Resonance Imaging Versus Cardiac Positron Emission Tomography for Risk Stratification for Ventricular Arrhythmias in Patients With Cardiac Sarcoidosis.
    Gowani Z; Habibi M; Okada DR; Smith J; Derakhshan A; Zimmerman SL; Misra S; Gilotra NA; Berger RD; Calkins H; Tandri H; Chrispin J
    Am J Cardiol; 2020 Nov; 134():123-129. PubMed ID: 32950203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET in possible cardiac sarcoidosis: Right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events.
    Tuominen H; Haarala A; Tikkakoski A; Kähönen M; Nikus K; Sipilä K
    J Nucl Cardiol; 2021 Feb; 28(1):199-205. PubMed ID: 30815833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Associated With Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis.
    Siontis KC; Santangeli P; Muser D; Marchlinski FE; Zeppenfeld K; Hoogendoorn JC; Narasimhan C; Sauer WH; Zipse MM; Kapa S; Vedantham V; Rosenthal DG; Robinson MR; Patton KK; Murgatroyd F; Chicos AB; Soejima K; Roukoz H; Sacher F; Bhan A; Appelbaum J; Dickfeld T; Mankad P; Ellenbogen KA; Kron J; Kim HM; Froehlich J; Eagle KA; Bogun FM; Crawford TC
    JAMA Cardiol; 2022 Feb; 7(2):175-183. PubMed ID: 34787643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
    Patel VN; Pieper JA; Poitrasson-Rivière A; Kopin D; Cascino T; Aaronson K; Murthy VL; Koelling T
    J Nucl Cardiol; 2022 Oct; 29(5):2460-2470. PubMed ID: 34505261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular (18)F-FDG uptake is an important indicator for cardiac involvement in patients with suspected cardiac sarcoidosis.
    Manabe O; Yoshinaga K; Ohira H; Sato T; Tsujino I; Yamada A; Oyama-Manabe N; Masuda A; Magota K; Nishimura M; Tamaki N
    Ann Nucl Med; 2014 Aug; 28(7):656-63. PubMed ID: 24889126
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Omote K; Naya M; Koyanagawa K; Aikawa T; Manabe O; Nagai T; Kamiya K; Kato Y; Komoriyama H; Kuzume M; Tamaki N; Anzai T
    J Nucl Cardiol; 2020 Dec; 27(6):2135-2143. PubMed ID: 30610523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
    Sperry BW; Ibrahim A; Negishi K; Negishi T; Patel P; Popović ZB; Culver D; Brunken R; Marwick TH; Tamarappoo B
    Am J Cardiol; 2017 May; 119(10):1663-1669. PubMed ID: 28343598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of phase analysis on gated single photon emission computed tomography in patients with cardiac sarcoidosis.
    Koyanagawa K; Naya M; Aikawa T; Manabe O; Kuzume M; Ohira H; Tsujino I; Tamaki N; Anzai T
    J Nucl Cardiol; 2021 Feb; 28(1):128-136. PubMed ID: 30815835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.